Skip Navigation
Skip to contents

ICDM 2023

Submission guidelines

After September 30, 2023 (Korean time), it will not be possible to make any modifications to the abstract due to the production and publication schedule of the abstract book.

The ICDM 2023 Organizing Committee cordially invites you to submit abstracts for oral presentations and poster exhibitions. All congress abstracts must be submitted online via the Online-Submission System. Please read the guidelines carefully before submitting your abstract.

Late-breaking abstract submission August 17(Thu)-24(Thu), 2023

*During the late-breaking period, only poster exhibitions are available, and oral presentations are not available.
*Travel grant applications are not available during the late-breaking period.

Notification of abstract acceptance September 4(Mon), 2023

Categories

Oral Presentation Poster Exhibition Topics
V V Basic & translational diabetes research
V V Clinical diabetes and therapeutics
V V Diabetes complications-clinical & epidemiology
V V Diabetes complications-basic & translational
V V Diabetes care & education
V V Others (clinical)
V V Others (basic & translational)
V V Korean medical students & medical trainees
- V Diabetes care & education diabetes education case (당뇨교육 증례)

Instruction

Language English
Title A concise title not exceeding 30 words recommended.
Format Objective-Methods-Results-Conclusion
Length of body 300 words
Authors Do not include degrees or titles.
Contents Extremely simple result with comment “The result will be discussed soon” will not be accepted.
Modification Until the deadline for abstract submission
Withdrawal The deadline for withdrawing the submitted abstract is September 8, 2023.

- Note that fax submissions will not be accepted.

Review & Notification of result

  • Submitted abstracts will be reviewed by the Committee of Scientific Affairs. Note that the committee may change the preferred presentation type of papers in order to effectively organize the program. Acceptance / rejection of abstracts will be notified to the submitters on the date of notification of abstract acceptance. Notification will be sent via email.
KDA 대한당뇨병학회Korean Diabetes Association
  • (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
  • Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
  • Business Registration Number: 106-82-31108 | Name of Representative: Kyu-Chang Won
Congress Secretariat (Planbear)
  • #1101, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
  • Tel: +82-2-6734-1011/1012/1013  E-mail: icdm@diabetes.or.kr